Back to top
more

AquaBounty Technologies (AQB)

(Real Time Quote from BATS)

$1.73 USD

1.73
3,910

-0.03 (-1.43%)

Updated Jun 5, 2024 01:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 248)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for AQB

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

AquaBounty Technologies, Inc. [AQB]

Reports for Purchase

Showing records 41 - 59 ( 59 total )

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 41

11/14/2019

Company Report

Pages: 7

No Fillets for Sale, but the Dry Spell Should End Next June; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 25.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 42

11/04/2019

Daily Note

Pages: 5

Can You Believe It? Barrons Missed Our Favorite Salmon Protagonist

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 43

10/16/2019

Daily Note

Pages: 3

The Aroma of Percolating Strategic Thought - Expansion in North America? Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 44

08/22/2019

Company Report

Pages: 7

June Unveils Sales and Expenses Unforeseen; Harvest on Schedule; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 25.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 45

07/11/2019

Company Report

Pages: 7

AquAdvantage Salmon Introduced in Indiana; Business Development Efforts Include International Expansion; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 25.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 46

06/03/2019

Company Report

Pages: 2

We are terminating coverage of AquaBounty Technologies Inc. due to reallocation of resources

Provider: DIAMOND EQUITY RESEARCH LLC

Analyst: DIAMOND H

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 47

05/23/2019

Company Report

Pages: 5

New Funding Allows Continued Progress with Indiana and Rollo Bay Farms

Provider: DIAMOND EQUITY RESEARCH LLC

Analyst: DIAMOND H

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 48

05/10/2019

Company Report

Pages: 7

March Quarter Report Importantly Marks Regulatory Progress; Fish Are Growing; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 25.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 49

03/28/2019

Company Report

Pages: 6

Lift of Import Alert Brings Long-Awaited AquAdvantage Eggs and Volume Production Potential to the U.S.; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 25.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 50

03/15/2019

Company Report

Pages: 5

AQB Enters Commercialization Stage as FDA Lifts Import Ban

Provider: DIAMOND EQUITY RESEARCH LLC

Analyst: DIAMOND H

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 51

12/27/2018

Daily Note

Pages: 4

USDA Labeling of Bioengineered Components Official: One Step Closer to the Lifting of the Import Ban; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 52

11/28/2018

Daily Note

Pages: 3

Approval Expected Prior to Year End; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 53

11/16/2018

Company Report

Pages: 7

Latest Report Shows Progress on Construction and Financing Fronts; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 25.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Medical - Biomedical and Genetics

Record: 54

11/07/2018

Company Report

Pages: 4

Successful Financing Complete, While Await FDA AquAdvantage Salmon Import Alert

Provider: DIAMOND EQUITY RESEARCH LLC

Analyst: DIAMOND H

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Unclassified

Record: 55

09/17/2018

Company Report

Pages: 8

Canadian Development on Target as Commercialization Efforts Mature; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 25.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Unclassified

Record: 56

08/17/2018

Company Report

Pages: 4

Reaffirm high growth potential secured by progress towards full-scale production

Provider: DIAMOND EQUITY RESEARCH LLC

Analyst: DIAMOND H

Price: 10.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Unclassified

Record: 57

08/08/2018

Company Report

Pages: 6

Panama-Raised Fish Sales Resume in Strength; Indiana Stocked With Traditional Eggs in Cash Generation Effort; Reit Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 25.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Unclassified

Record: 58

07/16/2018

Company Report

Pages: 25

Salmon Set for Rapid Commercial Growth with Aquaculture Boom - Initiation of Coverage

Provider: DIAMOND EQUITY RESEARCH LLC

Analyst: DIAMOND H

Price: 75.00

Research Provided by a Third Party

Company: AquaBounty Technologies, Inc.

Industry: Unclassified

Record: 59

06/28/2018

Company Report

Pages: 30

What We Eat Matters: Next-Gen Fish Farming Shifts Healthy Protein Development to Hyperdrive; Initiating Coverage at Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: DEDE K

Price: 75.00

Research Provided by a Third Party